Lisa von Moltke, former acting senior VP and head of clinical development at US global biotechnology company Alkermes, has moved to Seres Therapeutics as CMO. The Boston-headquartered biotechnology company Seres focuses on drugs to treat infectious, metabolic, and inflammatory diseases by targeting the underlying biology of the human microbiome.